Does sex alter the relationship between CYP2B6 variation, hydroxybupropion concentration and bupropion-aided smoking cessation in African Americans?:A moderated mediation analysis

Chenoweth, Meghan J and Peng, Annie R and Zhu, Andy Z X and Cox, Lisa Sanderson and Nollen, Nikki L and Ahluwalia, Jasjit S and Benowitz, Neal L and Knight, Jo and Swardfager, Walter and Tyndale, Rachel F (2022) Does sex alter the relationship between CYP2B6 variation, hydroxybupropion concentration and bupropion-aided smoking cessation in African Americans?:A moderated mediation analysis. Addiction, 117 (6). pp. 1715-1724. ISSN 0965-2140

[img]
Text (2B6_OHBUP_mediation_paper_Accepted_version)
2B6_OHBUP_mediation_paper_Accepted_version.pdf - Accepted Version
Restricted to Repository staff only until 3 December 2022.
Available under License Creative Commons Attribution-NonCommercial.

Download (324kB)

Abstract

BACKGROUND AND AIMS: CYP2B6, a genetically variable enzyme, converts bupropion to its active metabolite hydroxybupropion. CYP2B6 activity and bupropion-aided cessation differ between women and men. The aim of this study was to determine whether genetically normal (versus reduced) CYP2B6 activity increases bupropion-aided cessation in African American smokers via higher hydroxybupropion concentration, and whether this differs by sex. DESIGN AND SETTING: Secondary analysis of a smoking cessation clinical trial (NCT00666978). PARTICIPANTS/CASES: African American light smokers (≤ 10 cigarettes/day). INTERVENTIONS: Participants were treated with bupropion for 7 weeks. MEASUREMENTS: Participants with detectable bupropion and/or hydroxybupropion concentrations were divided into normal (n = 64) and reduced (n = 109) CYP2B6 activity groups based on the presence of decreased-function CYP2B6*6 and CYP2B6*18 alleles. Biochemically verified smoking cessation was assessed at week 3, end of treatment (7 weeks) and follow-up (26 weeks). FINDINGS: Normal (versus reduced) CYP2B6 activity was associated with increased cessation at week 7, which was mediated by higher hydroxybupropion concentration [odds ratio (OR) = 1.25, 95% confidence interval (CI) = 1.03, 1.78]; this mediation effect persisted at week 26 (OR = 1.23, 95% CI = 1.02, 1.70). The mediation effect was similar in women (n = 116; OR = 1.33, 95% CI = 1.01, 2.30) and men (n = 57; OR = 1.33, 95% CI = 0.92, 3.87). Moreover, sex did not appear to moderate the mediation effect, although this should be tested in a larger sample. CONCLUSIONS: In African American light smokers with verified early bupropion use, genetically normal CYP2B6 activity appears to be indirectly associated with greater smoking cessation success in a relationship mediated by higher hydroxybupropion concentration. The mediating effect of higher hydroxybupropion concentration on smoking cessation persists beyond the active treatment phase and does not appear to differ by sex.

Item Type:
Journal Article
Journal or Publication Title:
Addiction
Additional Information:
This is the peer reviewed version of the following article: Chenoweth, MJ, Peng, AR, Zhu, AZX, Cox, LS, Nollen, NL, Ahluwalia, JS, et al. Does sex alter the relationship between CYP2B6 variation, hydroxybupropion concentration and bupropion-aided smoking cessation in African Americans? A moderated mediation analysis. Addiction. 2022; 117: 1715– 1724. https://doi.org/10.1111/add.15742 which has been published in final form at: https://onlinelibrary.wiley.com/doi/10.1111/add.15742 This article may be used for non-commercial purposes in accordance With Wiley Terms and Conditions for self-archiving.
Uncontrolled Keywords:
/dk/atira/pure/subjectarea/asjc/2700/2701
Subjects:
ID Code:
164352
Deposited By:
Deposited On:
07 Jan 2022 14:40
Refereed?:
Yes
Published?:
Published
Last Modified:
03 Dec 2022 02:30